logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
D

Dinko Vitezić

faculty of medicine

15H指数
228论文数
1.2K被引数
收录论文 51
发表时间
logo
Pharmacoeconomics and outcomes research: Redefining value in the era of therapeutic innovation—Editorial药物经济学与结果研究：在治疗创新时代重新定义价值——社论
errBritish Journal of Clinical Pharmacology
IF3
err2026-09-29
err0
errOAAI
errAndrej Belančić; Slobodan Janković; Dinko Vitezić
err分享
err收藏
Nanotube-Assisted Motor Neuron and Neuromuscular Junction Stabilization in Spinal Muscular Atrophy: A Hypothesis for Adjunctive Therapy纳米管辅助脊髓性肌萎缩症中运动神经元和神经肌肉接头的稳定化：一种辅助治疗的假说
errNeurology International
IF3
err2026-05-02
err0
errOAAI
errAlmir Fajkić; Andrej Belančić; Kristina Pilipović; Valentino Rački; Silvestar Mežnarić; Tamara Janković; Elvira Meni Maria Gkrinia; Dinko Vitezić; Jasenka Mršić-Pelčić
err分享
err收藏
Time to accelerate rare disease research: AI-powered in silico trials, digital twin-driven RCTs and decision-grade real-world evidence加速罕见病研究的时间：人工智能驱动的体外试验、数字孪生驱动的随机对照试验和决策级真实世界证据
errBritish Journal of Clinical Pharmacology
IF3
err2026-05-01
err0
errOAAI
errBelancic, Andrej; Gkrinia, Elvira Meni Maria; Della Pasqua, Oscar; Sofat, Reecha; Vitezic, Dinko; Likic, Robert
err分享
err收藏
A systematic literature review of economic evaluations of setmelanotide塞美拉诺肽经济评估的系统文献综述
errEuropean Journal of Clinical Pharmacology
IF2.7
err2026-04-20
err0
PREAI
errBelancic, Andrej; Gkrinia, Elvira Meni Maria; Sel, Eda Kubra; Roncato, Rossana; Jankovic, Slobodan; Vitezic, Dinko
err分享
err收藏
The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations脊髓性肌萎缩症不断发展的治疗格局——一项关于研究性药物、新兴递送技术及战略创新的范围综述
errBritish Journal of Clinical Pharmacology
IF3
err2026-03-06
err0
errOAAI
errAndrej Belančić; Patrick Eustaquio; Elvira Meni Maria Gkrinia; Ivana Stević; Eugen Javor; Yun Wah Lam; Slobodan Janković; Dinko Vitezić
err分享
err收藏
Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis克罗地亚临床实践中SGLT2抑制剂的利用趋势：观察性分析
errMedicina-Lithuania
IF2.4
err2026-01-31
err0
errOAAI
errBelancic, Andrej; Stiglic, Marta Kucan; Jelakovic, Ana; Pecin, Ivan; Jelakovic, Bojan; Vitezic, Dinko
err分享
err收藏
Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology青年学者大会前会议：投资人才，变革临床药理学未来
errEuropean Journal of Clinical Pharmacology
IF2.7
err2025-12-15
err0
PREAI
errBelancic, Andrej; Litonius, Kaisa; Kulla, Noora; Likic, Robert; Jankovic, Slobodan; Vitezic, Dinko; Backman, Janne T.
err分享
err收藏
Cost-utility analysis of nusinersen-risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model克罗地亚脊髓性肌萎缩症患者中nusinersen-risdiplam转换的成本-效用分析：一种离散事件仿真模型
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2025-12-01
err0
PREAI
errBelancic, Andrej; Stevic, Ivana; Gkrinia, Elvira Meni Maria; Vitezic, Dinko; Jankovic, Slobodan
err分享
err收藏
Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy新翻译概念：轴突-肌肉外泌体信号传导作为一种新兴的脊髓性肌萎缩症治疗靶点
errBiomedicines 2025, Vol. 13, Page 2876
IF3.9
err2025-11-27
err0
errOAAI
errAlmir Fajkić; Andrej Belančić; Yun Wah Lam; Valentino Rački; Kristina Pilipović; Tamara Janković; Silvestar Mežnarić; Jasenka Mršić-Pelčić; Dinko Vitezić
err分享
err收藏
Letter to the editor: Expanding DPYD genotyping panels beyond current guidelines—real-world evidence and clinical–economic thoughts on inclusion of additional variants致编辑：扩展DPYD基因分型面板超越当前指南——关于纳入额外变异体的真实世界证据及临床–经济思考
errBritish Journal of Clinical Pharmacology
IF3
err2025-11-21
err0
errOAAI
errSilvestar Mežnarić; Jelena Rajič Bumber; Jasenka Mršić-Pelčić; Dinko Vitezić; Andrej Belančić
err分享
err收藏
The cost-effectiveness of cystic fibrosis transmembrane conductance regulator modulators: A systematic review of economic evaluations囊性纤维化跨膜电导调节因子调节剂的成本效益：经济评价的系统综述
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2025-11-01
err0
PREAI
errFaour, Andrea Katrin; Belancic, Andrej; Stimac, Ida; Gkrinia, Elvira Meni Maria; Goncalves, Judite; Pineda, Elisa; Vitezic, Dinko
err分享
err收藏
Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence批准用于脊髓性肌萎缩症的疗法的药代动力学: 对当前证据的叙述性回顾
errJOURNAL OF INTERNATIONAL MEDICAL RESEARCH
IF1.5
err2025-11-01
err0
PREAI
errSel, Eda Kubra; Gkrinia, Elvira Meni Maria; Roncato, Rossana; Vitezic, Dinko; Jankovic, Slobodan; Belancic, Andrej
err分享
err收藏
Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union安全性信号差异：欧洲联盟脊髓性肌萎缩症疗法疑似不良反应报告的趋势分析
errNeurology International 2025, Vol. 17, Page 165
IF3
err2025-10-08
err0
errOAAI
errAndrej Belančić; Petar Mas; Ivana Stević; Dinko Vitezić; Slobodan Janković
err分享
err收藏
Letter to the Editor: The Pharmacological Responsibility Chain - Mapping Competence Toward Responsible Prescribing致编辑：药物学责任链——绘制胜任力以实现负责任处方
errHospital Pharmacy
IF0.7
err2025-10-01
err0
PREAI
errFajkic, Almir; Belancic, Andrej; Vitezic, Dinko
err分享
err收藏
Methodological considerations on paracetamol pharmacokinetics in spinal muscular atrophy: A response to Zhao et al.关于脊髓性肌萎缩症中扑热息痛药代动力学的方法学考量：对Zhao et al.的回应
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2025-09-01
err0
errOAAI
errGkrinia, Elvira Meni Maria; Kristic, Iva; Belancic, Andrej; Vitezic, Dinko; Al-Sallami, Hesham S.
err分享
err收藏
Utilization of Child-Appropriate Medicines: Use of Pediatric Use Marketing Authorisation (PUMA) Products in Croatia儿童适宜药物的使用：克罗地亚儿科使用市场授权（PUMA）产品的应用
errJournal of Clinical Medicine 2025, Vol. 14, Page 5994
IF2.9
err2025-08-25
err0
PREAI
errAndrej Belančić; Marta Kučan Štiglić; Arnes Rešić; Almir Fajkić; Dinko Vitezić
err分享
err收藏
Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications脊髓性肌萎缩中的胶质细胞：关于非细胞自主机制和 therapeutic implications 的推测
errNeurology International 2025, Vol. 17, Page 41
IF3
err2025-08-23
err0
PREAI
errAndrej Belančić; Tamara Janković; Elvira Meni Maria Gkrinia; Iva Kristić; Jelena Rajič Bumber; Valentino Rački; Kristina Pilipović; Dinko Vitezić; Jasenka Mršić-Pelčić
err分享
err收藏
Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers克罗地亚25年来抗高血压药物使用趋势——对科学界和医疗保健提供者的警示
errBritish Journal of Clinical Pharmacology
IF3
err2025-08-11
err0
errOAAI
errAndrej Belančić; Marta Kučan Štiglić; Ana Jelaković; Bojan Jelaković; Dinko Vitezić
err分享
err收藏
Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy产前脊髓性肌萎缩管理：遗传筛查时代及宫内治疗新兴机遇
errbiomedicines
IF0
err2025-07-23
err0
errOAAI
errSilvestar Mežnarić; Andrej Belančić; Valentino Rački; Dinko Vitezić; Jasenka Mršić-Pelčić; Kristina Pilipović
err分享
err收藏
Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance脊髓性肌萎缩症疗法上市后安全性：EudraVigilance自发不良反应分析
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2025-05-03
err0
errOAAI
errBelancic, Andrej; Mas, Petar; Miletic, Lara; Bytyqi, Barbara Kovacic; Vitezic, Dinko
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Janne T. Backman
H 指数: 70 · 论文数: 269
D
Dušica Maysinger
H 指数: 57 · 论文数: 293
G
Giuseppe Capovilla
H 指数: 51 · 论文数: 191
R
Robert Nisticò
H 指数: 51 · 论文数: 186
R
Reecha Sofat
H 指数: 51 · 论文数: 213
查看更多